"We are launching our herbal skin care products Dermozone in India soon and targets revenue of USD 42 million over the next three years," a company's statement issued here said.
The company would also be looking at establishing India as a hub for managing all the technology, sales and customer support to other countries as well, it said.
The company also announced the appointment of Manjunatha K G as the Chief Operation Officer of Indo-Dermozone Herbal, who would lead and oversee the Indian operations.
Dermozone is globally recognised for its wide range of herbal skin care products especially its flagship brand- MedCare Ozonated olive oil, primarily used for the treatment of acne, fungal infections, dry skin, insect bites, athlete's foot, eczema, blisters, carbuncles, diabetic wounds, burns.
"We plan to enter the Indian market and will be soon formally launching our flagship product MedCare Ozonated olive oil," Dermozone Chairman and CEO K S Dharshan said.
"We are also looking at the option of setting up a manufacturing base in India in the near future based on the 'Make In India' policy of the government. A final decision on this will be taken in the first quarter of 2016," he further added.